广誉远: 广誉远中药股份有限公司关于控股股东增持公司股份计划实施完毕暨增持结果的公告

Core Viewpoint - The announcement details the completion of the share buyback plan by the controlling shareholder, Shennong Technology Group, which aimed to enhance investor confidence and support the company's stable development [1][2]. Group 1: Buyback Plan Overview - The buyback plan was initially disclosed on August 26, 2024, with a proposed investment range of 50 million to 100 million yuan over a 12-month period [1][3]. - The buyback was intended to be executed through centralized bidding and block trading, adhering to relevant regulations [1][4]. Group 2: Implementation Results - The buyback plan was completed on August 25, 2025, during which Shennong Technology Group acquired a total of 2,724,500 shares, amounting to 50.0288 million yuan (excluding taxes and fees) [4]. - Following the buyback, Shennong Technology Group's total shareholding increased to 74,233,468 shares, representing 15.17% of the total share capital [4]. Group 3: Compliance and Impact - The buyback actions complied with the Company Law, Securities Law, and other relevant regulations, ensuring that the company's shareholding structure remained within listing requirements [4]. - The completion of the buyback did not alter the controlling shareholder or actual controller of the company [4].